Aminopyrine Breath Test Predict Liver-related Events and Death in HCV-related Cirrhosis on SVR after DAA Therapy

Description

In patients with HCV-related advanced cirrhosis, the effects of SVR by DAAs on decompensation and liver deaths is less clearcut, since up to 30 % of patients do not improve, and no predictors of outcome have been identified. We used 13 C-aminopyrine breath test (ABT) to assess whether its changes can predict liver-related outcomes after DAA treatment in patients with HCV cirrhosis.

Additional details